China Everbright lures insurers, eyes fintech and healthcare
The mainland group's Hong Kong investment arm has been busy raising new funds this year and has outlined the types of assets it is targeting.
China Everbright Limited (CEL), the Hong Kong investment arm of mainland financial services group China Everbright, has raised four new funds this year and has identified key areas of investment for both its proprietary portfolio and the private equity strategies it manages for clients. They are elderly care, medical care, semiconductors, consumption upgrading and financial technology.
Sign In to Your Account
Access Exclusive AsianInvestor Content!
Please sign in to your subscription to unlock full access to our premium AI resources.
Free Registration & 7-Day Trial
Register now to enjoy a 7-day free trial—no registration fees required. Click the link to get started.
Note: This free trial is a one-time offer.
¬ Haymarket Media Limited. All rights reserved.